EVA1A and hepatocellular carcinoma: For example, miR-651-3p enhances cisplatin cytotoxicity in HCC cells by negatively regulating ATG3-mediated autophagy; miR-125b inhibits EVA1A-mediated autophagy to reverse oxaliplatin resistance in HCC cells (96, 97).